Summary
This is an expanded and updated report that includes:
- 55 New Pages of Material
- Charts, Timelines, Metrics and Financials Updated for 2011
- 5-Year Projection Data Spanning 2011-2016
- Expanded Competitive Environment Analysis
- New Section Presenting End-User Preferences (Scientist Panel)
Overview: Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymal stem cells increased 58% year-over-year from 2008 to 2009, and 112% from 2009 to 2010. Of most interest is that this rate of increase is projected to accelerate in 2011, making mesenchymal stem cells the fastest growing area of stem cell research.
Mesenchymal Stem Cell Market
BioInformant has been following the mesenchymal stem cell market since it was a minor market trend. As a result of escalating demand for MSC research, research tools and therapeutic solutions, BioInformant launched a broadly expanded version of the market report, “Mesenchymal Stem Cells, Advances & Applications,” published January 2011.
Highlights of the publication include:
- Detailed characterization of the market, emphasizing statistical trend assessment
- Exploration of recent product evolution and projected directions for development
- Data on end-user interests, needs and technical preferences (Scientist Panel)
- Overview of Therapeutic Progress
- Insight into Future Applications
- Detailed Evaluation of Profit Opportunities
- And Much More…
The report explores why no other stem cell type has experienced comparable demand increase among researchers. Is there a momentum effect? Are fundamentals driving the trend? Most importantly, what profit opportunities does this trend represent?
The timing of this report is designed to assist companies with annual planning and strategic decision-making to make 2011 a profitable year.
The timing of this report is designed to assist companies with annual planning and strategic decision-making to make 2011 a profitable year.
